Show simple item record

dc.contributor.authorNational Clinical Effectiveness Committee (NCEC)
dc.contributor.authorNational Patient Safety Office
dc.contributor.authorHealth Service Executive
dc.date.accessioned2022-05-26T15:15:09Z
dc.date.available2022-05-26T15:15:09Z
dc.date.issued2020-06
dc.identifier.urihttp://hdl.handle.net/10147/632003
dc.descriptionIn 2016, the Department of Health requested that the Health Research Board (HRB) fund an evidence synthesis service called HRB-CICER (Collaboration in Ireland for Clinical Effectiveness Reviews) to support the activities of the Ministerial appointed National Clinical Effectiveness Committee (NCEC). Following a competitive process, the Health Information and Quality Authority (HIQA) was awarded the contract for the five-year period from 2017 to 2022. The HRB-CICER team comprises a dedicated multidisciplinary research team supported by staff from the Health Technology Assessment (HTA) team in HIQA and the HRB Centre for Primary Care Research at the Royal College of Surgeons in Ireland (RCSI), as well as national and international clinical and methodological experts.en_US
dc.language.isoenen_US
dc.publisherDepartment of Healthen_US
dc.relation.ispartofseriesNational Clinical Guideline No. 29en_US
dc.subjectHAEMORRHAGEen_US
dc.subjectSURGERYen_US
dc.subjectRISKen_US
dc.titleUnexpected Intraoperative Life Threatening Haemorrhage: National Clinical Guideline No. 29: Annex A: Clinical Guidelines for the Management of Massive Haemorrhage – A systematic review.en_US
dc.typeOtheren_US
refterms.dateFOA2022-05-26T15:15:09Z


Files in this item

Thumbnail
Name:
Guideline_29_annexA.pdf
Size:
1.487Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record